SCHEMBL3849232

SCHEMBL3849232

CCOC(=O)c1ccc(-n2cnc3ccc(Br)cc32)cc1F

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SIK1 P57059 2/20 0.47
SIK2 Q9H0K1 2/20 0.47
SIK3 Q9Y2K2 2/20 0.47
ALDH1A1 P00352 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
MAPK1 P28482 2/20 0.44
RXFP1 Q9HBX9 2/20 0.42
GAA P10253 1/20 0.42
NPSR1 Q6W5P4 1/20 0.42
ATM Q13315 2/20 0.41
HTT P42858 1/20 0.41
MAPT P10636 1/20 0.41
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41
PKM P14618 1/20 0.41
LMNA P02545 1/20 0.40
THRB P10828 1/20 0.40
CYP1A2 P05177 1/20 0.40
CYP2C9 P11712 1/20 0.40
HPGD P15428 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL719657 0.77 DGAT1 (0.54) ALDH1A1SMN1; SMN2PKMLMNAGABRA1
Hydrochloric Acid SCHEMBL31426389 0.76 DGAT1 (0.53) ALDH1A1SMN1; SMN2PKMLMNAGABRA1
SCHEMBL3845583 0.75 PKM (0.43) SIK1SIK2SIK3ALDH1A1ATM
SCHEMBL13666321 0.74 FGFR1 (0.51) ALDH1A1SMN1; SMN2MAPK1GAAATM
SCHEMBL18584398 0.72 FGFR1 (0.68) SIK1SIK2SIK3ALDH1A1MAPK1
SCHEMBL31144757 0.71 HCAR1 (0.48) ALDH1A1MAPK1ATMHTTHPGD
SCHEMBL15638670 0.71 HCAR1 (0.48) ALDH1A1MAPK1ATMHTTHPGD
SCHEMBL15639073 0.71 FGFR1 (0.50) SIK1SIK2SIK3ALDH1A1SMN1; SMN2
SCHEMBL24074850 0.71 ESR2 (0.52) HTTMEN1KMT2AHPGD
SCHEMBL31621322 0.70 DGAT1 (0.50) ALDH1A1SMN1; SMN2GAAMAPTMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2048142-A2 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof Eisai R&D Management Co., Ltd. (JP) 2009-04-15 EP disclosed
EP-1382603-B1 NITROGENOUS FUSED-RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF EISAI R&D MAN CO LTD (JP) 2008-07-23 EP disclosed
US-7074801-B1 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof EISAI CO., LTD. (JP) 2006-07-11 US disclosed
EP-1382603-A1 NITROGENOUS FUSED−RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF Eisai Co., Ltd. (JP) 2004-01-21 EP disclosed